<DOC>
	<DOC>NCT01098617</DOC>
	<brief_summary>The aim of the study is to observe the effects of antihemostatic therapy including nonsteroidal antiinflammatory, anticoagulant and antiaggregant therapy and other patient and procedure related factors on the risk of endoscopic biliary sphincterotomy induced bleeding.</brief_summary>
	<brief_title>Antihemostatic Therapy and Endoscopic Biliary Sphincterotomy Induced Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Hospitalization Endoscopic sphincterotomy The patients whose warfarin treatment was stopped and INR was normalized prior to examination The patients who had undergone endoscopic cholangiography with no sphincterotomy Outpatient procedures</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>endoscopic sphincterotomy</keyword>
	<keyword>hemorrhage</keyword>
	<keyword>nonsteroidal antiinflammatory agents</keyword>
	<keyword>antiaggregants</keyword>
	<keyword>anticoagulants</keyword>
	<keyword>Endoscopic biliary sphincterotomy induced bleeding</keyword>
</DOC>